Current Report Filing (8-k)
03 März 2023 - 2:01PM
Edgar (US Regulatory)
0001729944
false
0001729944
2023-02-28
2023-02-28
0001729944
BACK:CommonStockParValue0.001PerShareMember
2023-02-28
2023-02-28
0001729944
BACK:WarrantsToPurchaseCommonStockMember
2023-02-28
2023-02-28
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): February 28, 2023
IMAC
Holdings, Inc.
(Exact
Name of Registrant as Specified in Charter)
Delaware |
|
001-38797 |
|
83-0784691 |
(State
or Other Jurisdiction |
|
(Commission |
|
(IRS
Employer |
of
Incorporation) |
|
File
Number) |
|
Identification
No.) |
1605
Westgate Circle, Brentwood, Tennessee |
|
37027 |
(Address
of Principal Executive Offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code: (844) 266-4622
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
|
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of Each Class |
|
Trading
Symbol |
|
Name
of Each Exchange on Which Registered |
Common
Stock, par value $0.001 per share |
|
BACK |
|
NASDAQ
Capital Market |
Warrants
to Purchase Common Stock |
|
IMACW |
|
NASDAQ
Capital Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
CURRENT
REPORT ON FORM 8-K
IMAC
Holdings, Inc. (the “Company”)
February
28, 2023
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On
February 28, 2023, Dr. Ben Lerner notified the Company of his resignation as the Company’s Chief Operating Officer to pursue other
interests, effective as of February 28, 2023. The Company will not replace the Chief Operating Officer position. Dr. Matthew Wallis,
the President of the Company, will continue to manage operating responsibilities for the Company’s medical clinic division.
Item 8.01. Other Events.
On
March 1, 2023, the Company issued a press release announcing the events described in Item 5.02. A copy of the press release is attached
hereto as Exhibit 99.1 and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
March 3, 2023 |
IMAC
HOLDINGS, INC. |
|
|
|
By: |
/s/
Jeffrey Ervin |
|
Name: |
Jeffrey
Ervin |
|
Title: |
Chief
Executive Officer |
IMAC (NASDAQ:IMAC)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
IMAC (NASDAQ:IMAC)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
Echtzeit-Nachrichten über IMAC Holdings Inc (NASDAQ): 0 Nachrichtenartikel
Weitere Imac Holdings, Inc. News-Artikel